Answers are grounded in this paper and cite their sources.
Tamoxifen is a nonsteroidal antiestrogen employed frequently in the treatment of breast cancer. An association between this drug and endometrial neoplasia has been reported. We report on 11 postmenopausal women with breast cancer who developed endometrial cancer while undergoing tamoxifen therapy and recommend aggressive investigation of vaginal bleeding in all women being treated with this agent.
No takes yet. Share an insight, caveat, or question.
Segna et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: